ELUT
Price:
$1.77
Market Cap:
$72.33M
Elutia Inc., a commercial-stage company, develops and commercializes drug-eluting biologics products for neurostimulation, wound care, and breast reconstruction in the United States. The company operates in three segments: Device Protection; Women's Health; and Cardiovascular. It offers CanGaroo Envelope, which is used to accommodate cardiac implantable electronic devices, such as pacemakers and internal defibrillators. The company also develops CanGarooRM, a combination of the CanGaroo envelope with antibiotics, to reduce the risk of infection after surgical implantation of an electronic device. In addition, it provides ProxiCor for cardiac tissue repair and pericardial closure; Tyke, an ex...[Read more]
Industry
Biotechnology
IPO Date
2020-10-08
Stock Exchange
NASDAQ
Ticker
ELUT
According to Elutia Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -1.34. This represents a change of -140.46% compared to the average of 3.31 of the last 4 quarters.
The mean historical PE Ratio of Elutia Inc. over the last ten years is -5.74. The current -1.34 PE Ratio has changed 2.23% with respect to the historical average. Over the past ten years (40 quarters), ELUT's PE Ratio was at its highest in in the September 2024 quarter at 24.09. The PE Ratio was at its lowest in in the March 2025 quarter at -6.21.
Average
-5.74
Median
-2.65
Minimum
-13.37
Maximum
-1.04
Discovering the peaks and valleys of Elutia Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 93.46%
Maximum Annual PE Ratio = -1.04
Minimum Annual Increase = -58.51%
Minimum Annual PE Ratio = -13.37
Year | PE Ratio | Change |
---|---|---|
2024 | -2.02 | 93.46% |
2023 | -1.04 | -41.71% |
2022 | -1.79 | -32.56% |
2021 | -2.65 | -58.51% |
2020 | -6.39 | -50.70% |
2019 | -12.96 | -3.12% |
The current PE Ratio of Elutia Inc. (ELUT) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-1.61
5-year avg
-2.78
10-year avg
-5.74
Elutia Inc.’s PE Ratio is
Company | PE Ratio | Market cap |
---|
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Elutia Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Elutia Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Elutia Inc.'s PE Ratio?
How is the PE Ratio calculated for Elutia Inc. (ELUT)?
What is the highest PE Ratio for Elutia Inc. (ELUT)?
What is the 3-year average PE Ratio for Elutia Inc. (ELUT)?
What is the 5-year average PE Ratio for Elutia Inc. (ELUT)?
How does the current PE Ratio for Elutia Inc. (ELUT) compare to its historical average?